These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9754597)

  • 1. Validity versus generalizability in clinical trial design and conduct.
    Hennekens CH; Buring JE
    J Card Fail; 1998 Sep; 4(3):239-41. PubMed ID: 9754597
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies for patient recruitment into clinical trials.
    Yusuf S
    J Card Fail; 1998 Sep; 4(3):235-6. PubMed ID: 9754595
    [No Abstract]   [Full Text] [Related]  

  • 3. Consecutive screening and enrollment in clinical trials.
    Julian D
    J Card Fail; 1998 Sep; 4(3):233. PubMed ID: 9754594
    [No Abstract]   [Full Text] [Related]  

  • 4. Consecutive screening and enrollment on clinical trials.
    Bjørn M; Brendstrup C; Karlsen S; Carlsen JE
    J Card Fail; 1999 Sep; 5(3):283-4. PubMed ID: 10496202
    [No Abstract]   [Full Text] [Related]  

  • 5. Consecutive screening and enrollment in clinical trials: the way to representative patient samples?
    Bjørn M; Brendstrup C; Karlsen S; Carlsen JE
    J Card Fail; 1998 Sep; 4(3):225-30; discussion 231. PubMed ID: 9754593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials in heart failure: can we expect the results to be replicated in clinical practice?
    Massie BM
    J Card Fail; 1998 Sep; 4(3):243-7. PubMed ID: 9754598
    [No Abstract]   [Full Text] [Related]  

  • 7. To screen or not to screen: how to improve clinical trials.
    Held P; Swedberg K
    J Card Fail; 1998 Sep; 4(3):237-8. PubMed ID: 9754596
    [No Abstract]   [Full Text] [Related]  

  • 8. A primer on the design, conduct, and interpretation of clinical trials.
    Appel LJ
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is right and what is wrong about evidence-based medicine?
    Julian DG
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S2-5. PubMed ID: 12950509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalizability of clinical trial results for bipolar disorder to community samples: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Hoertel N; Le Strat Y; Lavaud P; Dubertret C; Limosin F
    J Clin Psychiatry; 2013 Mar; 74(3):265-70. PubMed ID: 23561233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues in subgroup analyses and meta-analyses of clinical trials.
    Bigger JT
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S6-8. PubMed ID: 12950510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Time-and-Motion Study of Clinical Trial Eligibility Screening in a Pediatric Emergency Department.
    Dexheimer JW; Tang H; Kachelmeyer A; Hounchell M; Kennebeck S; Solti I; Ni Y
    Pediatr Emerg Care; 2019 Dec; 35(12):868-873. PubMed ID: 30281551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies.
    Srikanthan A; Vera-Badillo F; Ethier J; Goldstein R; Templeton AJ; Ocana A; Seruga B; Amir E
    Cancer Treat Rev; 2016 Feb; 43():67-73. PubMed ID: 26827694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bias control in clinical trials: masking or blinding.
    Galvez-Olortegui JK; Gonzales-Saldaña J; Garcia-Gomez I; Silva-Ocas I; Gutierrez-Arana J; Galvez-Olortegui T; Condor-Rojas YC
    Medwave; 2015 Dec; 15(11):e6349. PubMed ID: 26731671
    [No Abstract]   [Full Text] [Related]  

  • 15. Effort required in eligibility screening for clinical trials.
    Penberthy LT; Dahman BA; Petkov VI; DeShazo JP
    J Oncol Pract; 2012 Nov; 8(6):365-70. PubMed ID: 23598846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives in medicine. Generalizability of homogenous samples in clinical trials.
    Johnson MS
    J Assoc Acad Minor Phys; 1990; 1(2):31-3. PubMed ID: 2135695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study design: statistical and methodologic considerations.
    Rubenfeld GD
    Respir Care; 1995 Sep; 40(9):980-6. PubMed ID: 10152244
    [No Abstract]   [Full Text] [Related]  

  • 18. Rethinking trial eligibility in the NCD era.
    Lancet Oncol; 2015 Mar; 16(3):233. PubMed ID: 25752544
    [No Abstract]   [Full Text] [Related]  

  • 19. Massachusetts General Hospital SAFER criteria for clinical trials and research.
    Desseilles M; Witte J; Chang TE; Iovieno N; Dording C; Ashih H; Nyer M; Freeman MP; Fava M; Mischoulon D
    Harv Rev Psychiatry; 2013; 21(5):269-74. PubMed ID: 24651559
    [No Abstract]   [Full Text] [Related]  

  • 20. Statistical methods for clinical trials.
    Bailey A; Crook A; Machin D
    Blood Rev; 1994 Jun; 8(2):105-12. PubMed ID: 7950475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.